Skip to main content
Fig. 10 | Journal of Hematology & Oncology

Fig. 10

From: The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model

Fig. 10

MHCSZ-123 did not affect platelet count, bleeding time, or VWF levels in plasma. Peripheral platelet count (a), bleeding time (b), and VWF levels in plasma (c) at different time points after administration of varying doses of MHCSZ-123. Data represent mean ± SD (n = 6 animals per group). No significant differences were observed between doses

Back to article page